Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens

Rob J. Center, Adam K. Wheatley, Shahan M. Campbell, Adriana J. Gaeguta, Viv Peut, Sheilajen Alcantara, Carly Siebentritt, Stephen J. Kent, Damian F.J. Purcell

Research output: Contribution to journalArticlepeer-review

38 Citations (Scopus)

Abstract

We developed highly expressing clade B and AE DNA and envelope protein (Env) vaccines for evaluation in mice and macaques as DNA prime/protein boost regimens. High levels of Env-specific antibodies were induced in mice, albeit with limited neutralizing activity in vitro. A combined clade B and AE regimen induced high titer Env-specific antibody in two pigtail macaques that neutralized several strains of HIV-1. However, upon mucosal challenge with SHIVSF162P3 no protection from infection was observed. Although the vaccines tested provide a platform for inducing robust humoral immunity, further refinements to broaden coverage against divergent strains and induce mucosal immunity are needed.

Original languageEnglish
Pages (from-to)6605-6612
Number of pages8
JournalVaccine
Volume27
Issue number47
DOIs
Publication statusPublished - 5 Nov 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Envelope protein
  • HIV-1
  • Vaccine

Fingerprint

Dive into the research topics of 'Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens'. Together they form a unique fingerprint.

Cite this